EDAP TMS S.A. Receives U.S. FDA 510(k) Approval for Sonolith I-Sys

Globe Newswire -- LYON, France, Aug. 19, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that the U.S. Food and Drug Administration has granted 510(k) marketing clearance for its newly designed, high-end Sonolith I-Sys device.